3-deazaneplanocin A (DZNeP) HCl - CAS 120964-45-6
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
3-deazaneplanocin A (DZNeP) HCl
Catalog Number:
120964-45-6
Synonyms:
NSC 617989 HCl
CAS Number:
120964-45-6
Description:
3-deazaneplanocin A (DZNeP)HCl, an analog of adenosine, is a competitive inhibitor of S-adenosylhomocysteine hydrolase with Ki of 50 pM.
Molecular Weight:
298.73
Molecular Formula:
C12H14N4O3.HCl
COA:
Inquire
MSDS:
Inquire
Targets:
EZH2
Chemical Structure
CAS 120964-45-6 3-deazaneplanocin A (DZNeP) HCl

Related EZH2 Products


CPI-360
(CAS: 1802175-06-9)

CPI-360 is a potent, selective,and SAM-competitive EZH1 inhibitor with IC50 of 102.3 nM, >100-fold selectivity over other methyltransferases.

ZLD1039
(CAS: 1826865-46-6)

ZLD1039 potent, highly selective, and orally bioavailable small molecule inhibitor of EZH2, which inhibited the methyltransferase activity of EZH2 with high se...

EPZ011989
(CAS: 1598383-40-4)

EPZ011989 is a potent, orally-available EZH2 inhibitor with robust in vivo activity. EPZ011989 demonstrates significant tumor growth inhibition in a mouse xenog...

CAS 1346704-33-3 GSK343

GSK343
(CAS: 1346704-33-3)

GSK343 is a potent, selective inhibitor of EZH2 with cellular activity. GSK343 inhibits EZH2 with an IC50 of 4nM and is over 1000-fold selective for other HMTs...

CAS 1431612-23-5 UNC-1999

UNC-1999
(CAS: 1431612-23-5)

UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wildtype and mutant EZH2 as well as EZH1. UNC1999 was highly selective for E...

CAS 1418308-27-6 EI1

EI1
(CAS: 1418308-27-6)

EI1 inhibits cellular H3K27 methylation and activates Ezh2 target gene p16 expression.

CAS 1346574-57-9 GSK126

GSK126
(CAS: 1346574-57-9)

GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity. GSK126 decreases global H3...

EPZ011989 trifluoroacetate
(CAS: 1598383-41-5)

EPZ011989 trifluoroacetate is the trifluoroacetate salt form of EPZ011989. EPZ011989 is a potent and orally bioavailable inhibitor that specifically targets the...

CAS 1450655-76-1 CPI-169

CPI-169
(CAS: 1450655-76-1)

CPI-169 is a novel and potent EZH2 inhibitor, it decreases cellular levels of H3K27me3 and triggers cell cycle arrest and apoptosis in a variety of cell lines.

CAS 1396772-26-1 EPZ005687

EPZ005687
(CAS: 1396772-26-1)

EPZ005687 is a selective EZH2 enzyme inhibitor with Ki of 24 nM. It is 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyl...

GSK-503
(CAS: 1346572-63-1)

GSK-503 is a potent EZH2 inhibitor with potential anticancer activity. Increased activity of the epigenetic modifier EZH2 has been associated with different can...

CAS 102052-95-9 3-Deazaneplanocin A

3-Deazaneplanocin A
(CAS: 102052-95-9)

3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase that targets the degradation of EZH2.

CAS 120964-45-6 3-deazaneplanocin A (DZNeP) HCl

3-deazaneplanocin A (DZNeP) HCl
(CAS: 120964-45-6)

3-deazaneplanocin A (DZNeP)HCl, an analog of adenosine, is a competitive inhibitor of S-adenosylhomocysteine hydrolase with Ki of 50 pM.

CAS 1403254-99-8 EPZ-6438

EPZ-6438
(CAS: 1403254-99-8)

EPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. EPZ-6438 induces apoptosis and differentiation ...